Published

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The journal of pain
Date: 2022-10-01
Source: PubMed
DOI: 10.1016/j.jpain.2022.05.003
PubMed: 35643270

Authors

Dworkin RH Anderson BT Andrews N Edwards RR Grob CS Ross S Satterthwaite TD Strain EC

Watch author

Derived topics and classifications

psilocybin Chronic Pain Headache / Migraine Mechanism of Action Consciousness Spirituality Mystical Experience Clinical Trial Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14 The Effects of Psilocybin on Shared Experience in Film ProcessingClinicalTrials.gov · 2024-09-27 Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersClinicalTrials.gov · 2023-05-19 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14